Oomnitza Partners with Shasta Ventures and Riverside Acceleration Capital in Latest Round of Funding
Green dollar bonds from Chinese high yield real estate developers are rare, but property companies have the potential to push the green market in the region to the next level — and see some pricing
Intermediate Capital Group (ICG) has launched a second recovery fund, ICG Recovery Fund II, to invest in companies hit by the coronavirus crisis.
Dieter von Holtzbrinck Ventures (DvH Ventures) has announced the launch of its first Digital Health fund, which has held a first close on €60m.
Australian buyout major Pacific Equity Partners has hit an A$2.5bn hard cap final close for its sixth flagship fundraise.
GPs might seek to offer more attractive fund terms to incentivise LPs in the current climate, a global financial crisis. But what form might such incentives take, and are GP/LP relations likely to be affected
Private equity firms remain bullish on their portfolio investments despite the widespread chaos caused by the coronavirus crisis, new research suggests.
Meanwhile, global direct lending is on pace for its slowest year since 2015 in terms of capital raised
Alternative investment manager Ares Management bagged $9.1bn in new fund commitments in the second quarter of the year despite dealing with the coronavirus fallout.
Victor Christou joins as head of growth, responsible for seeking new investment opportunities in high-growth technology ventures
Opalesque Industry Update - Private Equity investment commitments from public pensions tracked by eVestment more than tripled from May to June this year, ending a three-month drop off in commitments that began in March as
Dutch private equity house Avedon Capital Partners has picked up at least €500m for its latest buyout fundraise, well above the total raised for its predecessor vehicle.
Versant Ventures has invested $30m in Switzerland-based Matterhorn Biosciences to launch the company and assist with the development of its T-cell therapy technology for cancer treatment.
Private debt fundraising is on pace for its slowest year in half a decade - but will a surge of newly-launched opportunistic vehicles hoping to profit from the coronavirus crisis turn those numbers around?
PME Investimentos has invested in a €4m series-A round for Portuguese company PicAdvanced, a manufacturer of optical transceivers.
Nordic Alpha Partners has backed a $14m series-B round for Germany-based 3D printing company DyeMansion, alongside the company's existing investors UVC Partners, BtoV Partners, KGAL and AM Ventures.
Versant Ventures and RA Capital Management have led a €66m series-A funding round for T-knife, an adoptive T-cell therapy developer based in Germany.
